医疗技术行业预计将鳍d new ways to keep us healthy, and to do so in a responsible manner. MedTech Europe and its members are committed to a high level of ethical business practices and have put in place strict guidelines to advise medical technology manufacturers on how to collaborate ethically with healthcare professionals (HCPs).

Brexit is a critical topic for the medical technology industry which has developed highly complex ties between the United Kingdom (UK) and the rest of the EU. Medical technologies are often moved between different EU countries during their production lifecycle and their clinical use. Crucially, up to 30% of our industry’s products have been authorised via UK Notified Bodies (CE marking) and could lose such authorisation overnight in the case of a “cliff edge” Brexit. MedTech Europe is tracking developments closely and has produced a position paper and other relevant documents to help medtech companies to navigate Brexit.

Medical technologies have the potential to save and improve lives, to inform citizens on the state of their health and to guide healthcare delivery.

Medical technologies are tightly regulated in the European Union. Before a medical technology can be legally placed on the EU market, a manufacturer must comply with the requirements of all applicable EU legislation and affix a CE mark to their device.

新的欧盟法规管理医疗设备（MD）和体外诊断（IVD）于2017年5月发布。MedtechEurope正在与我们的成员和当局合作，以支持公司在过渡期结束时遵守新立法 - 2021年 - 2021年bob多特蒙德app用于MDS和2022的IVD。

As the spread of the coronavirus COVID-19 continues to impact the health of people and the economy of countries around the world, the medical technology industry is working to support all ongoing efforts against this pandemic.

MedTech行业开发了有助于在社区护理环境和人们家中提供卫生服务的产品。这些技术挽救生命，方便患者，并有效利用医疗保健资源。

In addition to the medical technology sector’s core goal of saving lives and improving health, environmental and social considerations are an integral part of our industry’s operations. We acknowledge that preserving a healthy environment and building socially responsible value chains are essential in keeping human beings in good health. Our industry needs to be at the forefront of addressing challenges related to sustainable healthcare.

Information is power. Medical technology companies need to stay on top of the latest trends impacting their business. Informed decisions require up-to-date market intelligence from a trusted service.

Medical technologies generate information and data that are critical for the prevention, diagnosis, treatment, monitoring and management of health and lifestyle. More and more of this data is now digitised; it can be stored and accessed on electronic health records and personal devices, shared among patients and healthcare professionals, and aggregated and processed with data advanced analytics
MedTech Europe works with policymakers and relevant stakeholders to realise the potential of data-driven healthcare. Together we focus on legal and regulatory issues (privacy, safety), technology (cybersecurity, interoperability), the business case (incentives, reimbursement), and emerging technologies (precision medicine, artificial intelligence).

bob多特蒙德appMedTech Europe与全球机构，决策者和利益相关者有关医疗技术公司面临的关键国际问题。

研究与创新（R＆I）是欧洲医疗技术领域的命脉。R＆I的行业投资提供了增强寿命的设备，诊断和数字解决方案。欧盟对R＆I的支持为学术界和行业提供了宝贵的机会，可以创造新的知识并利用它来应对我们社会面临的最大挑战。对明天的医疗创新的追求需要新的，广泛的合作伙伴关系。R＆I基于协作最有影响力。bob多特蒙德app欧洲Medtech欧洲致力于与公共和私营部门的其他人合作，以找到解决我们共同挑战的共同解决方案。

Vision loss can have a profound impact on those affected, resulting in lost independence and significantly limiting daily activities. Ageing increases the risk of eye diseases that can lead to visual impairment. The MedTech industry develops products that reduce the burden of eye disease on individuals, families and the wider economy. These innovations add enormous value to European society.

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAI) are among the biggest global public health challenges of our time. These infections cause significant morbidity and mortality, put pressure on health systems, and incur rising direct and indirect costs.
医疗技术可以通过防止，检测，监测和管理感染和抵抗来帮助解决这些问题。

Cardiovascular diseases can impact millions of people of all ages. Diseases of the heart and circulatory system are the leading cause of death in Europe and a major cause of disability.

医疗技术行业提供high-quality solutions to the burden of cardiovascular diseases on individuals, families and the wider society. These innovations, which span the full spectrum of patient care from diagnosis to cure, save lives and add tremendous value to European society.

骨科s is the medical specialty that focuses on injuries and diseases of the human body's musculoskeletal system. This complex system includes your bones, joints, ligaments, tendons, muscles, and nerves and allows you to move, work, and be active.

医学技术行业发展产品,减少the burden of musculoskeletal diseases on individuals, families and the wider economy. These innovations improve quality of life and add enormous value to European society.

1 in 11 adults around the world have diabetes. That’s about 60 million people across Europe, equivalent to the total Italian population. This number increases significantly every year. If current trends continue, diabetes will be the number one health threat in the coming years.

欧洲糖尿病部门旨在通过采取有意义的集体行动来避免糖尿病的流血，并在诊断时，将人们置于护理中心，并给他们带来充实无忧的生活，旨在扭转这一趋势。